Mobix Labs Reports 41% Revenue Decline and Significant Losses for December 2025 Quarter

Mobix Labs, Inc. reported a significant decline in financial performance for the three months ending December 31, 2025, as detailed in its latest 10-Q filing. The company generated total net revenue of $1.875 million, a decrease of 41% from $3.169 million in the same period the previous year. This decline was primarily driven by a 32% drop in product revenue, which fell to $1.335 million from $1.951 million, and a 56% decrease in service revenue, which dropped to $540,000 from $1.218 million. The gross profit also decreased sharply to $581,000, down 66% from $1.687 million in the prior year.

In terms of operational efficiency, Mobix Labs reported a loss from operations of $8.833 million, an improvement compared to the $14.630 million loss recorded in the same quarter of 2024. The company’s total operating expenses decreased by 40% to $9.414 million, largely due to reduced selling, general, and administrative expenses, which fell to $8.972 million from $15.706 million. The company also experienced a notable increase in interest expenses, which rose to $1.380 million from $211,000, reflecting higher borrowings and interest rates.

Mobix Labs has made strategic moves to enhance its market position, including the issuance of 1.914 million shares of Class A Common Stock under its At The Market Offering Agreement, generating net proceeds of $1.254 million. The company also entered into a public offering agreement on January 6, 2026, to sell 30 million shares at $0.20 per share, which is expected to raise approximately $5.135 million after fees. These actions are part of the company's strategy to secure additional capital to support ongoing operations and product development.

As of December 31, 2025, Mobix Labs reported total assets of $32.724 million, down from $37.113 million at the end of the previous fiscal quarter. The company’s liabilities also decreased significantly to $28.057 million from $37.449 million, primarily due to the reclassification of certain liability-classified warrants to equity. However, the company continues to face challenges, including a working capital deficit of $22.370 million and an accumulated deficit of $160.713 million, raising concerns about its ability to continue as a going concern without additional financing.

Looking ahead, Mobix Labs anticipates continued operating losses and negative cash flows, necessitating further capital raises to meet its obligations. The company has expressed substantial doubt regarding its ability to maintain liquidity over the next twelve months, emphasizing the need for strategic financial management and potential restructuring of its operations to achieve profitability in the future.